Pharmacodynamic modeling of in vitro activity of marbofloxacin against Escherichia coli strains. - Archive ouverte HAL Access content directly
Journal Articles Antimicrobial Agents and Chemotherapy Year : 2011

Pharmacodynamic modeling of in vitro activity of marbofloxacin against Escherichia coli strains.

(1) , (2) , (1) , (1)
1
2
Martin Andraud
Claire Chauvin
  • Function : Author
  • PersonId : 896707
Pascal Sanders
Michel Laurentie
  • Function : Author
  • PersonId : 896708

Abstract

A mathematical pharmacodynamic model was developed to describe the bactericidal activity of marbofloxacin against Escherichia coli strains with reduced susceptibility levels (determined using MICs) under optimal and intestinal growth conditions. Model parameters were estimated using nonlinear least-square curve-fitting procedures for each E. coli strain. Parameters related to bactericidal activity were subsequently analyzed using a maximum-effect (E(max)) model adapted to account for a direct and a delayed effect. While net growth rates did not vary significantly with strain susceptibility, culture medium had a major effect. The bactericidal activity of marbofloxacin was closely associated with the concentration and the duration of exposure of the bacteria to the antimicrobial agent. The value of the concentration inducing a half-maximum effect (C(50)) was highly correlated with MIC values (R(2) = 0.87 and R(2) = 0.94 under intestinal and optimal conditions, respectively). Our model reproduced the time-kill kinetics with good accuracy (R(2) of >0.90) and helped explain observed regrowth.

Dates and versions

anses-00577909 , version 1 (17-03-2011)

Identifiers

Cite

Martin Andraud, Claire Chauvin, Pascal Sanders, Michel Laurentie. Pharmacodynamic modeling of in vitro activity of marbofloxacin against Escherichia coli strains.. Antimicrobial Agents and Chemotherapy, 2011, 55 (2), pp.756-61. ⟨10.1128/AAC.00865-10⟩. ⟨anses-00577909⟩

Collections

ANSES
26 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More